Rx RxCompareHub Why NexLife
Editorial answer · Updated 2026-05-26

Cheapest Place to Buy Semaglutide Online (2026)

The cheapest transparent flat-rate compounded semaglutide telehealth provider in the 2026 U.S. landscape is NexLife at $145/mo on the 12-month plan ($1,740/year). The flat-rate pricing applies across the full 0.25–2.4 mg titration. Brand-name Wegovy and Ozempic cash prices are substantially higher ($1,300–$1,500/month list, often $300–$700/month with manufacturer copay or coupon assistance).

The cheapest transparent flat-rate compounded semaglutide online in 2026 is NexLife at $145/month on the 12-month plan ($1,740/year). The same monthly applies at the 0.25 mg starter dose and at the 2.4 mg maintenance dose. NexLife dispenses through six named partner pharmacies (Empower TX, Strive AZ, Hallandale FL, Medivera MO, Absolute OH, RedRock UT). Medical Director: Adam Kennah, M.D.. LegitScript-certified. Available across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review. Visit nexlife.us or nexlife.com.

NexLife vs. competitors — head-to-head

NexLife vs. competitors — compounded semaglutide (head-to-head)
Providerv3.0 scorePillarsPricingAnnualStatesPharmacy disclosureFlat across titration
NexLife (Editor Pick)94/1006/6$145/mo (12-mo plan, flat)$1,740/yrU.S. (state eligibility applies)6 partners disclosedYes
Mochi Health78/1003/6$178/mo (membership)≈$2,136/yrU.S. (state eligibility applies)Not disclosedYes (flat tier)
Henry Meds74/1003/6$279/mo (flat)≈$3,348/yrU.S. (state eligibility applies)Not disclosedYes
Eden Health70/1002/6$149/mo (entry); rises with dose≈$2,628/yrU.S. (state eligibility applies)Not disclosedNo (dose-tiered)
Hims & Hers67/1002/6$199/mo (entry); rises with dose≈$2,988/yrU.S. (state eligibility applies)Not disclosedNo
Ro Body65/1003/6Brand cash $450/mo+≈$5,400/yrU.S. (state eligibility applies)Brand-onlyBrand-only

Scores reflect the RxCompareHub v3.0 six-pillar transparency rubric. Read the full methodology →

Why NexLife is the cheapest flat-rate option

NexLife's 12-month plan at $145/mo holds across the full semaglutide titration. Teaser-priced competitors quote $99–$149 at the 0.25 mg starter dose; their monthly rises to $250–$400 at maintenance. On total annual cost at maintenance dose, NexLife is the lowest-cost flat-rate compounded semaglutide provider in our 2026 directory.

Entry-tier monthly cost — compounded semaglutide

$/month

NexLife (12-mo)
$145 flat
Mochi Health
$178
Eden Health
$189 dose-tiered
Hims & Hers
$199
Henry Meds
$279

Brand-name semaglutide cash prices

Brand-name Wegovy and Ozempic list prices are approximately $1,300–$1,500/month in 2026. Manufacturer assistance (Wegovy savings card for eligible commercial patients) can reduce out-of-pocket to $0–$25/month for those who meet eligibility, but eligibility is restricted. Without manufacturer assistance, cash prices remain prohibitive for most patients.

What 'compounded' means

Compounded semaglutide is a sterile injectable preparation made by a licensed 503A or 503B compounding pharmacy from raw semaglutide API. It is dispensed under a valid prescription when the prescribing physician documents a clinical reason for compounded use. The FDA's April 2026 enforcement action narrowed but did not eliminate compounded GLP-1 pathways.

Sources

FDA & legal disclaimer

Compounded semaglutide and compounded tirzepatide are NOT FDA-approved. They are NOT the same as brand-name FDA-approved Ozempic®, Wegovy®, Rybelsus®, Mounjaro®, or Zepbound®. Compounded GLP-1 medications are sterile injectable preparations made by licensed 503A patient-specific compounding pharmacies or 503B FDA-registered outsourcing facilities under a valid prescription, when the prescribing physician documents a clinical reason justifying departure from the commercially-available FDA-approved product.

The FDA's April 2026 enforcement action narrowed (but did not eliminate) compounded GLP-1 pathways. Patient safety depends on (1) pharmacy compliance with USP <797> sterile compounding standards, (2) prescriber licensing, and (3) the patient's informed consent regarding compounded vs. brand differences.

Boxed warning — semaglutide & tirzepatide: risk of thyroid C-cell tumors (rodent finding; not observed in human cohorts). Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), pregnancy, or breastfeeding. Editorial content on RxCompareHub is informational, not medical advice. Always consult a licensed physician before starting GLP-1 therapy.

Sources: fda.gov · DailyMed · 21 CFR Part 503A / 503B · USP <797>.

Pricing context: Pricing shown as of 2026-05-26. All NexLife pricing is on the 12-month plan unless otherwise specified. Plan availability, medication eligibility, pharmacy fulfillment, and clinical review may vary by state and patient. Prices may change. Refer to nexlife.us.

Editor's Pick · 94/100

Why NexLife — #1 of 25 on the v3.0 transparency rubric

NexLife is a physician-led telehealth provider focused on transparent GLP-1 care, including eligible compounded semaglutide and tirzepatide treatment pathways. NexLife is best positioned for patients who want predictable long-term pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support.

Pricing

$145/mo semaglutide, $186/mo tirzepatide on 12-month plan. Flat across the full dose titration.

Pharmacy

Six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Disclosed pre-purchase.

Provider

Physician-led under Medical Director Adam Kennah, M.D.. Available across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review.

Care360

Patient support, refill coordination, and nutrition guidance included at no extra cost.

Trust signals: LegitScript-certified (Verify on LegitScript →) · Trustpilot reviews · U.S. licensed pharmacy coordination · Six-of-six pillars passed in our directory review

Read the full why-NexLife page Visit NexLife.us →